×
About 325 results

ALLMedicine™ Pediatric Vaccines Center

Research & Reviews  129 results

Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Ital...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595078
Journal of Preventive Medicine and Hygiene; Icardi G, Orsi A et. al.

Nov 5th, 2020 - In Italy, three hexavalent pediatric vaccines are available: two are ready-to-use (RTU) as pre-filled syringes, while the third must be reconstituted (need-for-reconstitution [NFR]). The formulation is related to the vaccination timing, safety of ...

A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944453
Journal of Virology; Liang B, Matsuoka Y et. al.

Oct 29th, 2020 - Live-attenuated pediatric vaccines for intranasal administration are being developed for human respiratory syncytial virus (RSV), an important worldwide pediatric respiratory pathogen that lacks a licensed vaccine or suitable antiviral drug. We ev...

Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543330
Clinical Infectious Diseases : an Official Publication Of... Anderson EJ, Campbell JD et. al.

Sep 18th, 2020 - While adult clinical trials of COVID-19 vaccines have moved quickly into Phase 3 clinical trials, clinical trials have not started in children in the US. The direct COVID-19 impact upon children is greater than that observed for a number of other ...

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
https://clinicaltrials.gov/ct2/show/NCT03691610

Apr 23rd, 2020 - Study duration per participant is approximately 1 year in Group 1 and Group 2, and 10 months in Group 3 and Group 4. This duration includes a safety follow-up contact at 6 months after the last vaccination.

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
https://clinicaltrials.gov/ct2/show/NCT03673462

Apr 23rd, 2020 - Study duration per participant is approximately 16 months, which includes a safety follow-up contact at 6 months after the final vaccination

see more →

Guidelines  3 results

Recommendations for Prevention and Control of Influenza in Children, 2018–2019
http://pediatrics.aappublications.org/content/early/2018/08/30/peds.2018-2367
Diseases, Committee on Infectious

Sep 2nd, 2018 - The authors of this statement update the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children. Highlights for the upcoming.

Recommended Childhood and Adolescent Immunization Schedules: United States, 2018
http://pediatrics.aappublications.org/content/141/3/e20180083
Committee on Indfectious Diseases

Feb 28th, 2018 - The recommended childhood and adolescent immunization schedules for 2018 have been approved by the American Academy of Pediatrics, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC), the Americ.

HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)]
https://gsksource.com/pharma/content/gsk/source/us/en/brands/hiberix/pi/po.html

HIBERIX is a primary series and booster Hib vaccine to help protect against Haemophilus influenzae type b.

see more →

Drugs  11 results see all →

Clinicaltrials.gov  159 results

Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Ital...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595078
Journal of Preventive Medicine and Hygiene; Icardi G, Orsi A et. al.

Nov 5th, 2020 - In Italy, three hexavalent pediatric vaccines are available: two are ready-to-use (RTU) as pre-filled syringes, while the third must be reconstituted (need-for-reconstitution [NFR]). The formulation is related to the vaccination timing, safety of ...

A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944453
Journal of Virology; Liang B, Matsuoka Y et. al.

Oct 29th, 2020 - Live-attenuated pediatric vaccines for intranasal administration are being developed for human respiratory syncytial virus (RSV), an important worldwide pediatric respiratory pathogen that lacks a licensed vaccine or suitable antiviral drug. We ev...

Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543330
Clinical Infectious Diseases : an Official Publication Of... Anderson EJ, Campbell JD et. al.

Sep 18th, 2020 - While adult clinical trials of COVID-19 vaccines have moved quickly into Phase 3 clinical trials, clinical trials have not started in children in the US. The direct COVID-19 impact upon children is greater than that observed for a number of other ...

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
https://clinicaltrials.gov/ct2/show/NCT03691610

Apr 23rd, 2020 - Study duration per participant is approximately 1 year in Group 1 and Group 2, and 10 months in Group 3 and Group 4. This duration includes a safety follow-up contact at 6 months after the last vaccination.

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
https://clinicaltrials.gov/ct2/show/NCT03673462

Apr 23rd, 2020 - Study duration per participant is approximately 16 months, which includes a safety follow-up contact at 6 months after the final vaccination

see more →

News  23 results

Pediatric Vaccines & Infectious Diseases: September 2019
https://www.mdedge.com/pediatrics/article/208198/pediatric-vaccines-infectious-diseases-september-2019?channel=168

Sep 16th, 2019 - Click here to read the supplement. The 2019 Pediatric Vaccines & Infectious Diseases supplement features a selection of articles published in Pediatric News , with commentary by Kristina A.

New research in otitis media
https://www.mdedge.com/familymedicine/article/203911/infectious-diseases/new-research-otitis-media/page/0/2?channel=271
MDedge Pediatrics;

Jul 1st, 2019 - Immunity The notion that young children get AOM because of Eustachian tube dysfunction in their early years of life (horizontal anatomy) may be true, but there is more to the story. After 10 years of work, the scientists in my research group have.

Pediatric Vaccines & Infectious Diseases: Fall 2017
https://www.mdedge.com/pediatrics/article/149533/dermatology/pediatric-vaccines-infectious-diseases-fall-2017

Oct 17th, 2017 - An editorial supplement to Pediatric News. Articles Include: The perpetual challenge of emerging infections Teen vaccines: Where are we now, and how can we go further? Parental reasons for HPV nonvaccination are shifting Make HIV testing of adoles.

ICAAC: Synergistic effects of two pediatric vaccines highlighted
https://www.mdedge.com/pulmonary-health-hub/article/103002/vaccines/icaac-synergistic-effects-two-pediatric-vaccines
Bruce Jancin

Sep 24th, 2015 - SAN DIEGO – The potent synergistic benefits of coadministration of rotavirus vaccine and pneumococcal conjugate vaccine in young children are uniquely highlighted by a natural experiment conducted in southern Israel as described by Dr. Ron Dagan a.

see more →